NAD⁺ 1000 mg pen — analytical-grade research peptideAstranordic NAD+ Pen · 1000 mg / pen
Fig. 01 · Specimen
Pre-filled pen
In the box
  • ·Pre-filled 1000 mg pen
  • ·Alcohol swabs
MitochondrialClass IAstranordic NAD+ Pen

NAD⁺ 1000 mg pen

High-dose NAD⁺ pen — 1000 mg pre-reconstituted.

High-dose pen format NAD⁺ — double the 500 mg vial kit, in a pre-filled pen device.

Designation
Astranordic NAD+ Pen
CAS no.
53-84-9
Molecular formula
C21H27N7O14P2
MW (Da)
663.43
Residues
Purity
≥ 99.0%
Form
Pre-filled pen
Dose
1000 mg / pen
Class
Class I
Dispatch · per unit
£165GBP
≈ €195 · 0.00306 BTC
1
In stock·Same-day dispatch (order by 09:30 UK)·Tracked24 Royal Mail £6.50·Not shipped to USA
Clinical status: Research reagent. Not therapeutic.
§ A Overview

What the peptide is.

Astranordic pen format of NAD⁺ — suitable for extended mitochondrial research protocols.

Proposed mechanism

As per NAD⁺ 500 mg kit.

§ B Laboratory handling

Reconstitution, storage, and handling.

Lab-technical guidance for the researcher handling the material. Not therapeutic dosing, not administration guidance — those are not within the scope of this supply.

Reconstitution
Recommended solvent
Pre-reconstituted
Typical volume
N/A
Notes
  • Cold-chain shipped.
Storage
Lyophilised
Pre-filled pen — store 2–8 °C. Pen is shipped cold-chain; after first use it may be kept at 2–8 °C.
Reconstituted
Pens are pre-reconstituted. Once opened, use within the manufacturer-stated window (typically 4 weeks refrigerated).
Shelf life · sealed
See pen label — typically 18–24 months sealed under refrigeration.
Shelf life · reconstituted
Once pen is opened: ~4 weeks at 2–8 °C.
Handling notes
  • Protect from light.
§ C Certificate of Analysis

This lot, documented.

Every shipment is accompanied by a signed four-page analytical report including the HPLC chromatogram, ESI-MS spectrum, purity calculation, and sample handling chain-of-custody.

The report you will receive is specific to the lot dispatched to you. The display below is a current representative example.

astranordic nad pen · batch.log
LIVE
04:22:11lot 26-04-A received ┈ 5.00 g
04:22:40weight check ┈ PASS ±0.4 mg
04:23:12sample → janoshik ┈ 50 mg
04:23:12tracking #jnk-9218334
05:18:03HPLC result ┈ 99.24 %
05:18:04MS obs 4729.42 Da ┈ PASS
05:18:05coa.pdf signed ┈ attached
05:18:06lot approved ┈ LIVE
janoshik.report.txt
SIGNED
REPORT ID     JA-26-04-012
SUBJECT       NAD⁺ 1000 mg pen
DESIGNATION   Astranordic NAD+ Pen
LOT           26-04-A
METHOD        RP-HPLC, ESI-MS
COLUMN        C18, 250 x 4.6 mm, 5 um
MOBILE PHASE  A: 0.1% TFA in H2O
              B: 0.1% TFA in ACN
GRADIENT      5 -> 65% B over 20 min
FLOW RATE     1.0 mL/min
DETECTION     UV 214 nm
INJECTION     20 uL @ 0.5 mg/mL
---
PURITY (A%)   99.00
MASS EXP.     663.43 Da
MASS OBS.     663.45 Da
---
CONCLUSION    Identity CONFIRMED · Purity PASS
SIGNED BY     J. Novak, MSc · Janoshik Analytical SVK
DATE          2026-04-11
representative chromatogram · A214 nmRT 8.42 min
Representative trace · Lot-specific COA included with every dispatch
purity≥ 99.0%
§ E Peer-reviewed studies

Research references for NAD⁺ 1000 mg pen.

0 peer-reviewed publications. Links resolve to PubMed. DOIs are provided where available.

    § F Questions

    About this peptide.

    For general site, shipping, and payment questions see the full FAQ.

    Research use only

    This peptide is supplied by Omega Grade for in vitro laboratory research use. It is not a drug, food, cosmetic, or dietary supplement. It is not approved by the FDA, EMA, MHRA, PMDA, or any other regulatory authority for any therapeutic indication.

    No claim of therapeutic benefit is made or implied. The material is not intended for human or veterinary consumption, administration, or any form of self-experimentation. By purchasing, you acknowledge the researcher terms and accept full responsibility for local import compliance and all handling.